2024    2023    2022    2021    2020    2019    2018    2017    2016   

2021

Articles

151 - 

Determinants of Therapeutic Lag in Multiple Sclerosis

Izanne Roos, Emmanuelle Leray, Federico Frascoli, Romain Casey, J William L Brown et al.

Multiple Sclerosis Journal, 2021, 27 (12), pp.1838-1851.

DOI : https://doi.org/10.1177/1352458520981300

Pubmed : 33423618

 

152 - 

Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis

Izanne Roos, Emmanuelle Leray, Romain Casey, Dana Horakova, Eva Havrdova et al.

Neurology, 2021, 97 (9), pp.e869-e880.

DOI : https://doi.org/10.1212/WNL.0000000000012354

Pubmed : 34193589

 

153 - 

Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study

Ronan Roussel, Patrice Darmon, Matthieu Pichelin, Thomas Goronflot, Yawa Abouleka et al.

Diabetes, Obesity and Metabolism, 2021, 23 (5), pp.1162-1172.

DOI : https://doi.org/10.1111/dom.14324

Pubmed : 33528920

 

154 - 

Prise en charge de la douleur postopératoire : l’étude AlgoSFAR, un audit national de 3315 patients Postoperative pain management: the AlgoSFAR study, a national audit of 3315 patients

Pauline Rouxel, Laurie Tran, Philippe Sitbon, Valéria Martinez, Hélène Beloeil et al.

Prise en charge de la douleur postopératoire : l’étude AlgoSFAR, un audit national de 3315 patients. Anesthésie & Réanimation, 2021, 7 (6), pp.376-386.

DOI : https://doi.org/10.1016/j.anrea.2021.08.004

 

155 - 

Improving the decision to switch from first to second-line therapy in MS: a dynamic scoring system

C. Sabathe, Romain Casey, S. Vukusic, Emmanuelle Leray, G. Mathey et al.

Multiple Sclerosis Journal, 2021, ECTRIMS 2021 Committees, 27 (Suppl 2), pp.22-24.

DOI : https://doi.org/10.1177/13524585211044647

 

156 - 

Changes in prostate cancer screening practice by blood PSA testing between 2011 and 2017, a French population-based study

Lucie-Marie Scailteux, Valérian Capelle, Frédéric Balusson, Emmanuel Oger, Sébastien Vincendeau et al.

Current Medical Research and Opinion, 2021, 37 (8), pp.1435-1441.

DOI : https://doi.org/10.1080/03007995.2021.1944075

Pubmed : 34134580

 

157 - 

A survey of biomedical journals to detect editorial bias and nepotistic behavior

Alexandre Scanff, Florian Naudet, Ioana A. Cristea, David Moher, Dorothy V. M. Bishop et al.

PLoS Biology, 2021, 19 (11), pp.e3001133.

DOI : https://doi.org/10.1371/journal.pbio.3001133

Pubmed : 34813595

 

158 - 

Autism Spectrum and Other Neurodevelopmental Disorders in Children of Immigrants: A Brief Review of Current Evidence and Implications for Clinical Practice

Heiko Schmengler, David Cohen, Sylvie Tordjman, Maria Melchior

Frontiers in Psychiatry, 2021, 12,

DOI : https://doi.org/10.3389/fpsyt.2021.566368

Pubmed : 33815159

 

159 - 

Long-term outcomes in heart failure with preserved ejection fraction: predictors of cardiovascular and non-cardiovascular mortality

A. Shahim, M. Hourqueig, L. H. Lund, G. Savarese, E. Oger et al.

European Journal of Heart Failure, 2021, 23, pp.24-25.

 

160 - 

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

Sifat Sharmin, Mathilde Lefort, Johanna Balslev Andersen, Emmanuelle Leray, Dana Horakova et al.

CNS Drugs, 2021, 35 (11), pp.1217-1232.

DOI : https://doi.org/10.1007/s40263-021-00860-7

Pubmed : 34536228